期刊
HUMAN MOLECULAR GENETICS
卷 24, 期 4, 页码 1077-1091出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddu521
关键词
-
资金
- Parkinson's UK [G-1203]
- Biotechnology and Biological Sciences Research Council (BBSRC)
- Medical Research Council (MRC)
- DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Germany
- Medical Research Council [MC_U132681855] Funding Source: researchfish
- Parkinson's UK [G-1203] Funding Source: researchfish
- MRC [MC_U132681855] Funding Source: UKRI
A central pathological hallmark of Parkinson's disease (PD) is the presence of proteinaceous depositions known as Lewy bodies, which consist largely of the protein alpha-synuclein (aSyn). Mutations, multiplications and polymorphisms in the gene encoding aSyn are associated with familial forms of PD and susceptibility to idiopathic PD. Alterations in aSyn impair neuronal vesicle formation/transport, and likely contribute to PD pathogenesis by neuronal dysfunction and degeneration. a Syn is functionally associated with several Rab family GTPases, which perform various roles in vesicle trafficking. Here, we explore the role of the endosomal recycling factor Rab11 in the pathogenesis of PD using Drosophila models of aSyn toxicity. We find that aSyn induces synaptic potentiation at the larval neuromuscular junction by increasing synaptic vesicle (SV) size, and that these alterations are reversed by Rab11 overexpression. Furthermore, Rab11 decreases aSyn aggregation and ameliorates several aSyn-dependent phenotypes in both larvae and adult fruit flies, including locomotor activity, degeneration of dopaminergic neurons and shortened lifespan. This work emphasizes the importance of Rab11 in the modulation of SV size and consequent enhancement of synaptic function. Our results suggest that targeting Rab11 activity could have a therapeutic value in PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据